Concepedia

Publication | Open Access

A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

10

Citations

18

References

2024

Year

Abstract

ClinicalTrials.gov, https://www.clinicaltrials.gov, NCT0474420.

References

YearCitations

Page 1